260 related articles for article (PubMed ID: 24826489)
1. MMPI-2 Symptom Validity (FBS) Scale: psychometric characteristics and limitations in a Veterans Affairs neuropsychological setting.
Gass CS; Odland AP
Appl Neuropsychol Adult; 2014; 21(1):1-8. PubMed ID: 24826489
[TBL] [Abstract][Full Text] [Related]
2. Minnesota Multiphasic Personality Inventory-2 revised form Symptom Validity Scale-Revised (MMPI-2-RF FBS-r; also known as Fake Bad Scale): psychometric characteristics in a nonlitigation neuropsychological setting.
Gass CS; Odland AP
J Clin Exp Neuropsychol; 2012; 34(6):561-70. PubMed ID: 22384793
[TBL] [Abstract][Full Text] [Related]
3. The relation between symptom validity testing and MMPI-2 scores as a function of forensic evaluation context.
Wygant DB; Sellbom M; Ben-Porath YS; Stafford KP; Freeman DB; Heilbronner RL
Arch Clin Neuropsychol; 2007 May; 22(4):489-99. PubMed ID: 17350796
[TBL] [Abstract][Full Text] [Related]
4. The construct validity of the Lees-Haley Fake Bad Scale. Does this scale measure somatic malingering and feigned emotional distress?
Butcher JN; Arbisi PA; Atlis MM; McNulty JL
Arch Clin Neuropsychol; 2003 Jul; 18(5):473-85. PubMed ID: 14591444
[TBL] [Abstract][Full Text] [Related]
5. A comparison of selected MMPI-2 and MMPI-2-RF validity scales in assessing effort on cognitive tests in a military sample.
Jones A; Ingram MV
Clin Neuropsychol; 2011 Oct; 25(7):1207-27. PubMed ID: 21902565
[TBL] [Abstract][Full Text] [Related]
6. Detecting negative response bias with the Fake Bad Scale, Response Bias Scale, and Henry-Heilbronner Index of the Minnesota Multiphasic Personality Inventory-2.
Dionysus KE; Denney RL; Halfaker DA
Arch Clin Neuropsychol; 2011 Mar; 26(2):81-8. PubMed ID: 21148668
[TBL] [Abstract][Full Text] [Related]
7. The Mild Brain Injury Atypical Symptoms (mBIAS) scale in a mixed clinical sample.
Lippa SM; Axelrod BN; Lange RT
J Clin Exp Neuropsychol; 2016 Sep; 38(7):721-9. PubMed ID: 27159359
[TBL] [Abstract][Full Text] [Related]
8. Examination of the MMPI-2 restructured form (MMPI-2-RF) validity scales in civil forensic settings: findings from simulation and known group samples.
Wygant DB; Ben-Porath YS; Arbisi PA; Berry DT; Freeman DB; Heilbronner RL
Arch Clin Neuropsychol; 2009 Nov; 24(7):671-80. PubMed ID: 19797242
[TBL] [Abstract][Full Text] [Related]
9. Equations for prorating the symptom validity scale (FBS) for the 370-item MMPI-2.
Fox DD
Clin Neuropsychol; 2010 Oct; 24(7):1238-42. PubMed ID: 20924982
[TBL] [Abstract][Full Text] [Related]
10. Neurobehavioral symptom validity in U.S. Department of Veterans Affairs (VA) mild traumatic brain injury evaluations.
Ashendorf L
J Clin Exp Neuropsychol; 2019 May; 41(4):432-441. PubMed ID: 30712457
[TBL] [Abstract][Full Text] [Related]
11. The MMPI-2 Symptom Validity Scale (FBS) not influenced by medical impairment: a large sleep center investigation.
Greiffenstein MF
Assessment; 2010 Jun; 17(2):269-77. PubMed ID: 20124428
[TBL] [Abstract][Full Text] [Related]
12. Examining the relationship between the reconstructed scales and the fake bad scale of the MMPI-2.
Downing SK; Denney RL; Spray BJ; Houston CM; Halfaker DA
Clin Neuropsychol; 2008 Jul; 22(4):680-8. PubMed ID: 18597202
[TBL] [Abstract][Full Text] [Related]
13. Incremental validity of the MMPI-2-RF over-reporting scales and RBS in assessing the veracity of memory complaints.
Gervais RO; Ben-Porath YS; Wygant DB; Sellbom M
Arch Clin Neuropsychol; 2010 Jun; 25(4):274-84. PubMed ID: 20335183
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a Response Bias Scale (RBS) for the MMPI-2.
Gervais RO; Ben-Porath YS; Wygant DB; Green P
Assessment; 2007 Jun; 14(2):196-208. PubMed ID: 17504891
[TBL] [Abstract][Full Text] [Related]
15. Detection of symptom exaggeration with the MMPI-2 in litigants with malingered neurocognitive dysfunction.
Larrabee G
Clin Neuropsychol; 2003 Feb; 17(1):54-68. PubMed ID: 12854011
[TBL] [Abstract][Full Text] [Related]
16. The validity of the MMPI-2/MMPI-2-RF Symptom Validity Scale (FBS/FBS-r) is established: reply to Nichols (2017).
Larrabee GJ; Bianchini KJ; Boone KB; Rohling ML
Clin Neuropsychol; 2017 Nov; 31(8):1401-1405. PubMed ID: 28994350
[TBL] [Abstract][Full Text] [Related]
17. Validating the usefulness of the NSI validity-10 with the MMPI-2-RF.
Gradwohl BD; Mangum RW; Tolle KA; Pangilinan PH; Bieliauskas LA; Spencer RJ
Int J Neurosci; 2020 Sep; 130(9):926-932. PubMed ID: 31928283
[No Abstract] [Full Text] [Related]
18. Utility of the Deceptive-Subtle items in the detection of malingering.
Bagby RM; Nicholson R; Buis T
J Pers Assess; 1998 Jun; 70(3):405-15. PubMed ID: 9841263
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the Fake Bad Scale and other MMPI-2 validity scales with personal injury litigants.
Tsushima WT; Tsushima VG
Assessment; 2001 Jun; 8(2):205-12. PubMed ID: 11428699
[TBL] [Abstract][Full Text] [Related]
20. The MMPI-2/MMPI-2-RF Symptom Validity Scale (FBS/FBS-r) is not a measure of 'litigation response syndrome': commentary on Nichols and Gass (2015).
Larrabee GJ; Bianchini KJ; Boone KB; Rohling ML
Clin Neuropsychol; 2017 Nov; 31(8):1387-1395. PubMed ID: 28829224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
